Rationale for using data on biological variation

Clinical Chemistry and Laboratory Medicine

Volumn 53, Issue 6, 2015, Pages 863-870

  Ricós, Carmen ^a   Álvarez, Virtudes ^a,b   Perich, Carmen ^a,c   Fernández Calle, Pilar ^a,d   Minchinela, Joana ^a,e   Cava, Fernando ^a,f   Biosca, Carmen ^a,g   Boned, Beatriz ^a,h   Doménech, Mariví ^a   García Lario, José Vicente ^a,i   Simón, Margarita ^a,j   Fernández, Pilar Fernández ^a   Diaz Garzón, Jorge ^a,d   González Lao, Elisabet ^a,j  

^a Sociedad Espanola de Bioquimica Clinica y Patologia Molecular   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e Barcelonès Nord i Vallès Oriental   (Spain)

^f HOSPITAL UNIVERSITARIO INFANTA SOFÍA   (Spain)

^g HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^h HOSPITAL ROYO VILLANOVA   (Spain)

ⁱ HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^j L'Anoia i El Garraf ^*  (Spain)

more..

Author keywords

biological variation; patient safety; quality assurance; quality specification

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA 2 MACROGLOBULIN; ALPHA FETOPROTEIN; C REACTIVE PROTEIN; CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CALCIUM; CARCINOEMBRYONIC ANTIGEN; CERULOPLASMIN; CHOLESTEROL; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C; LIPOPROTEIN A; OSTEOCALCIN; TROPONIN I;

ANALYTICAL PARAMETERS; BIOLOGICAL VARIATION DATABASE; BREAST CARCINOMA; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CHRONIC LIVER DISEASE; CLINICAL LABORATORY; CONFERENCE PAPER; DATA BASE; HEALTH CARE QUALITY; HEPATITIS B; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LUNG CARCINOMA; MEDICINE; OVARY CARCINOMA; PAGET BONE DISEASE; PATHOLOGY; PATIENT MONITORING; PERFORMANCE MEASUREMENT SYSTEM; PRIORITY JOURNAL; QUALITY CONTROL; ANALYSIS OF VARIANCE; BIOASSAY; BLOOD; FACTUAL DATABASE; OBSERVER VARIATION; REFERENCE VALUE; STANDARDS;

ANALYSIS OF VARIANCE; BIOLOGICAL ASSAY; CREATININE; DATABASES, FACTUAL; HUMANS; OBSERVER VARIATION; QUALITY CONTROL; REFERENCE VALUES;

EID: 84929074319     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2014-1142     Document Type: Conference Paper

References (44)

1. Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989;27:409-37.
2. Fraser CG. Biological variation: from principles to practice. Washington, DC: AACC Press, 2001.
3. Ricós C, álvarez V, Cava F, Hernández A, García-Lario JV, Hernández A, et al. Current data-bases on biological variation: pros and cons. Scand J Clin Lab Invest 1999;59:491-500.
4. Minchinela J, Ricós C, Perich C, Fernández-Calle P, Álvarez V, Doménech MV, et al. Available at: http://www.westgard.com/biodatabase-2014-update.htm. Accessed: 14 Nov 2014.
5. Perich C, Minchinela J, Ricós C, Fernández-Calle P, Álvarez V, Doménech MV, et al. Biological variation database: structure and criteria used for generation and update. Clin Chem Lab Med 2015;53:299-305.
6. Fraser CG, Cummings ST, Wilkinson SP, Neville RG, Knox JD, Ho O, et al. Biological variability of 26 clinical chemistry analytes in elderly people. Clin Chem 1989;35:783-6.
7. Bailey D, Bevilcqua V, Colantonio DA, Pasic MD, Perumal N, Chan M, et al. Pediatric within-day biological variation and quality specifications for 38 biochemical markers in the CALIPER cohort. Clin Chem 2014;60:518-29.
8. Eckfeldt J, Chambless L, Shen Y. Short-term, within-person variability in clinician chemistry test results. Arch Pathol Lab Med 1994;118:496-500.
9. Carlsen S, Petersen HP, Skeie S, Skadberg O, Sandberg S. Within-subject biological variation of glucose and HbA1c in healthy persons and in type 1 diabetes patients. Clin Chem Lab Med 2011;49:1501-7.
10. Juan-Pereira L. Variabilitat biològica intraindividual de les magnituds bioquímiques. Aplicacions clíniques. Doctoral Thesis. Barcelona: Barcelona University, 1989.
11. Williams GZ, Widdowson GM, Penton J. Individual character of variation in time-series studies of healthy people II. Differences in values for clinical chemical analytes in serum among demographic groups by age and sex. Clin Chem 1978;24:313-20.
12. Davie SJ, Whiting KL, Gould BJ. Biological variation in glycated proteins. Ann Clin Biochem 1993;30:260-4.
13. Ricós C, Iglesias N, García-Lario JV, Simón M, Cava F, Hernández A, et al. Within-subject biological variation in disease: collated data and clinical consequences. Ann Clin Biochem 2007;44:343-52.
14. Fraser CG, Williams P. Short-term biological variation of plasma analytes in renal disease. Clin Chem 1983;29:508-10.
15. Seibel MJ, Koeller M, Van der Velden E, Diel I. Long-term variability of long turnover markers in patients with non-metastatic breast cancer. Clin Lab 2002;48:579-82.
16. Ditadi R, Peloso L, Gion M. Within-subject biological variation in disease: the case of tumor markers. Ann Clin Biochem 2008;45:225-8.
17. Trapé J, Franquesa J, Sala M, Doménech M, Montesinos J, Catot S, et al. Determination of biological variation of α-fetoprotein and choriogonadotropin (β-chain) in disease-free patients with testicular cancer. Clin Chem Lab Med 2010;48:1799-801.
18. Hölzel WG. Intra-individual variation of analytes in serum from patients with chronic liver disease. Clin Chem 1987;33:1133-6.
19. Reinhard M, Erlandsen EJ, Randers E. Biological variation of cys-tatin C and creatinine. Scand J Clin Lab Invest 2009;69:861-6.
20. Jorde R, Sundsfjord J. Intra-individual variability and longitudinal changes in glycaemic control in patients with type I diabetes mellitus. Diabetic Med 2000;17:451-6.
21. Hernández C, Francisco G, Chacón P, Mesa J, Simó R. biological variation of lipoprotein (a) in a diabetic population. Analysis of the causes and clinical implications. Clin Chem Lab Med 2003;41:1075-80.
22. Howey JE, Browning MC, Fraser CG. Selecting the optimum specimen for assessing slight albuminuria, and a strategy for clinical investigation: novel uses of data on biological variation. Clin Chem 1987;33:2034-8.
23. Rossi E, Adams LA, Ching HL, Bulsara M, MacQuillan GC, Jeffrey GP. High biological variation of serum hyaluronic acid and Hepascore, a biochemical marker model for the prediction of liver fibrosis. Clin Chem Lab Med 2013;21:1107-14.
24. Mora J. Variabilitat intraindividual dels marcadors tumorals. Doctoral Thesis. Barcelona: Barcelona Authonomic University, 1993.
25. Álvarez L, Ricós C, Peris P, Guañabens N, Monegal A, Pons F, et al. Components of biological variation of biochemical markers of bon turnover in Paget's bone disease. Bone 2000;26:571-6.
26. Fraser CG, Stevenson HP, Kennedy IM. Biological variation data are necessary prerequisites for objective autoverification of clinical laboratory data. Accred Qual Assur 2002;7:455-60.
27. Fraser CG. Reference change values. Clin Chem Lab Med 2012;50:807-12.
28. Kenny D, Fraser CG, Petersen PH, Kallner A. Strategies to set analytical quality specifications in laboratory medicine. Consensus agreement. Scand J Clin Lab Invest 1999;59:585.
29. Adams O, Cooper G, Fraser CG, Hubmann M, Johnes G, Plebani M, et al. Collective opinion paper on findings of the 2011 convocation of experts on laboratory quality. Clin Chem Lab Med 2012;49:793-802.
30. Cotlove E, Harris EK, Williams EZ. Biological and analytical components of variation in long-term studies of serum constituents in normal subjects. Clin Chem 1970;16:1028-32.
31. Gowans EM, Petersen PH, Blaabjerg O, Horder M. Analytical goals for the acceptance of common reference intervals for laboratories throughout a geographical area. Scand J Clin Lab Invest 1988;48:757-64.
32. Fraser CG, Petersen PH, Libeer JC, Ricós C. Proposals for setting generally applicable quality goals solely based on biology. Ann Clin Biochem 1997;34:8-12.
33. Sandberg S. Summing up and further work. 1st EFLM Strategic Conference. Defining analytical performance goals 15 years after the Stockholm Conference. Available at: http://www.efcclm.org/index.php/educational-material.html. Accessed: 22 Apr 2015.
34. Ricós C, Ramón F, Salas A, Buño A, Calafell R, Morancho J, et al. Minimum analytical quality specifications of interlaboratory comparisons: agreement among Spanish EQA organizers. Clin Chem Lab Med 2012;50:455-61.
35. Centers for Medicare and Medicaid Services, Department of Health and Human Services. Part 493-Laboratory Requirements: Clinical Laboratory Improvement Amendments of 1988. 42CFR 430 to end. US Government Printing Office. Available at: http://wwwn.westgard.com/clia.htm (revised 26 September, 2011).
36. Richtlinie der Bundesärztekammer zur Qualitätssicherung laboratoriumsmedizinischer Untersuchungen. Dt Ärzteblatt 2008;105:341-5.
37. Jansen R, Jassam N, Thomas A, Perich C, Fernández-Calle P, Faria AP, et al. A category 1 EQA scheme for comparison of interlaboratory performance and method performance. An international pilot study in the framework of the Calibration 2000 project. Clin Chim Acta 2014;432:90-8.
38. Perich C, Ricós C, Álvarez V, Biosca C, Boned B, Cava F, et al. External quality assurance programs as a tool for verifying standardization of measurement procedures: pilot collaboration in Europe. Clin Chim Acta 2014;432:82-9.
39. Harris EK, Yasaka T. On the calculation of a "reference change" for comparing two consecutive measurements. Clin Chem 1983;29:25-30.
40. Fraser CG. Making better use of differences in serial laboratory results. Ann Clin Biochem 2011;49:1-3.
41. Lund F, Petersen PH, Fraser CG, Solétörmos G. Calculation of limits for significant bidirectional changes in two or more serial biomarker results based on a computer simulation model. Ann Clin Biochem 2014 Sep 23 pii: 0004563214555163.
42. Biosca C, Ricós C, Lauzurica R, Galimany R, Petersen PH. Reference change value concept combining two delta values to predict crises in renal post-transplantation. Clin Chem 2001;47:2146-8.
43. Simundic AM, Bartlett WA, Fraser CG. Biological variation: a still evolving facet of laboratory medicine. Ann Clin Biochem 2015;52:189-90.
44. Aarsand AK, Roraas T, Sandberg S. Biological variation-reliable data is essential. Clin Chem Lab Med 2015;53:153-4.